<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Annals of Clinical and Experimental Neurology</journal-id><journal-title-group><journal-title xml:lang="en">Annals of Clinical and Experimental Neurology</journal-title><trans-title-group xml:lang="ru"><trans-title>Анналы клинической и экспериментальной неврологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-5473</issn><issn publication-format="electronic">2409-2533</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">731</article-id><article-id pub-id-type="doi">10.25692/ACEN.2021.1.11</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Clinical analysis</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Клинический разбор</subject></subj-group><subj-group subj-group-type="article-type"><subject>Unknown</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Results of percutaneous rhizotomy for trigeminal neuralgia in patients with multiple sclerosis</article-title><trans-title-group xml:lang="ru"><trans-title>Результаты чрескожной ризотомии при тригеминальной невралгии у больных с рассеянным склерозом</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Tyurnikov</surname><given-names>Vladimir M.</given-names></name><name xml:lang="ru"><surname>Тюрников</surname><given-names>Владимир Михайлович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>lolaaskarova@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Askarova</surname><given-names>Lola Sh.</given-names></name><name xml:lang="ru"><surname>Аскарова</surname><given-names>Лола Шавкатовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>lolaaskarova@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Trifonova</surname><given-names>Olga V.</given-names></name><name xml:lang="ru"><surname>Трифонова</surname><given-names>Ольга Васильевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>lolaaskarova@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zakharova</surname><given-names>Maria N.</given-names></name><name xml:lang="ru"><surname>Захарова</surname><given-names>Мария Николаевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>lolaaskarova@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Gushcha</surname><given-names>Artem O.</given-names></name><name xml:lang="ru"><surname>Гуща</surname><given-names>Артем Олегович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>lolaaskarova@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Research Center of Neurology</institution></aff><aff><institution xml:lang="ru">ФГБНУ «Научный центр неврологии»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2021-03-24" publication-format="electronic"><day>24</day><month>03</month><year>2021</year></pub-date><volume>15</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>89</fpage><lpage>94</lpage><history><date date-type="received" iso-8601-date="2021-03-24"><day>24</day><month>03</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, Tyurnikov V.M., Askarova L.S., Trifonova O.V., Zakharova M.N., Gushcha A.O.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, Tyurnikov V.M., Askarova L.S., Trifonova O.V., Zakharova M.N., Gushcha A.O.</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">Tyurnikov V.M., Askarova L.S., Trifonova O.V., Zakharova M.N., Gushcha A.O.</copyright-holder><copyright-holder xml:lang="ru">Tyurnikov V.M., Askarova L.S., Trifonova O.V., Zakharova M.N., Gushcha A.O.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://annaly-nevrologii.com/pathID/article/view/731">https://annaly-nevrologii.com/pathID/article/view/731</self-uri><abstract xml:lang="en"><p><bold>Introduction. </bold>Neuropathic pain in trigeminal neuralgia (TN) is one of the most common and debilitating symptoms in patients with multiple sclerosis (MS). This condition in MS is due to the demyelination of pontine afferent fibers in the sensory root of the trigeminal nerve. The area of demyelination is usually located in the ventrolateral pons between the exit of the trigeminal nerve root and the trigeminal nucleus, which is confirmed on MRI. In some cases, neurovascular compression also plays a role in afferent fiber injury, leading to the so-called double crush effect. Conservative therapy for TN in patients with MS is often insufficiently effective, thus increasing the pertinence of surgical treatment.</p> <p><bold>Materials and methods.</bold> The article reviews current pharmacological and surgical approaches to treating TN, findings from the literature, and our data on the safety and efficacy of percutaneous radiofrequency rhizotomy (PRR) for TN, based on the surgical treatment of 52 patients with MS at the Research Center of Neurology.</p> <p><bold>Results. </bold>PRR works by interrupting the connection between peripheral receptor zones and the hyperactive trigeminal structures in the brainstem. All patients were discharged from the hospital on day 2–3 after surgery, with complete pain resolution. There were early and late relapses in some instances, which required a repeated PRR.</p> <p><bold>Conclusion.</bold> PRR is a symptomatic surgical method that is safe, repeatable, and effective for treating TN in patients with MS, in whom pharmacological therapy has been ineffective or who could not tolerate it.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Введение. </bold>Нейропатическая боль при тригеминальной невралгии (ТГН) является одним из частых и изнуряющих симптомов у больных рассеянным склерозом (РС). В основе развития данного синдрома при РС лежит демиелинизация афферентных волокон интрапонтинной части чувствительного корешка тройничного нерва. Очаг демиелинизации обычно расположен в вентролатеральной части моста между зоной выхода корешка тройничного нерва и его ядра, что подтверждается данными МР-томографии. В ряде случаев в развитии повреждения афферентных волокон играет роль и нейроваскулярная компрессия, что приводит к так называемому двойному удару. Консервативная терапия при ТГН у больных РС чаще всего недостаточно эффективна, что делает вопрос хирургического лечения крайне актуальным.</p> <p><bold>Материалы и методы.</bold> В статье рассмотрены современные фармакотерапевтические и хирургические подходы к лечению ТГН, приведены литературные и собственные данные оценки эффективности и безопасности чрескожной радиочастотной селективной ризотомии (ЧРСР) при ТГН на основе опыта хирургического лечения 52 пациентов с РС в ФГБНУ НЦН.</p> <p><bold>Результаты. </bold>Лечебный эффект ЧРСР достигался за счет разрыва связи периферических рецепторных зон с гиперактивными стволовыми тригеминальными структурами. Все пациенты были выписаны из стационара на 2–3-и сутки после операции с полным регрессом болевого синдрома. В некоторых случаях отмечались ранние и поздние рецидивы, что потребовало повторения процедуры ЧРСР.</p> <p><bold>Заключение.</bold> ЧРСР является безопасным, повторяемым и эффективным методом симптоматического хирургического лечения ТГН у больных РС при неэффективности/непереносимости медикаментозной терапии.</p></trans-abstract><kwd-group xml:lang="en"><kwd>trigeminal neuralgia</kwd><kwd>multiple sclerosis</kwd><kwd>percutaneous radiofrequency rhizotomy</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>невралгия тройничного нерва</kwd><kwd>рассеянный склероз</kwd><kwd>чрескожная радиочастотная селективная ризотомия</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Katusic S., Williams D.B., Beard M., et al. Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945-1984. Neuroepidemiology. 1991; 10(5–6):276–281. DOI: 10.1159/000110284. PMID: 1798430.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Di Stefano G., Maarbjerg S., Truini A. Trigeminal neuralgia secondary to multiple sclerosis: from the clinical picture to the treatment options. J Headache Pain. 2019; 20(1): 20. DOI: 10.1186/s10194-019-0969-0. PMID: 30782116</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Hooge J.P., Redekop W. Trigeminal neuralgia in multiple sclerosis. Neurology. 1995; 45(7): 1294–1296. DOI: 10.1212/wnl.45.7.1294. PMID: 7617185.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Tyurnikov V.M., Peresedova A.V., Gushcha A.O., Zavalishin I.A. Percutaneous high-frequency selective rhizotomy in the trigeminal neuralgia therapy in multiple sclerosis. Neuromuscular Diseases. 2012(1):19–24. DOI: 10.17650/2222-8721-2012-0-1-19-24.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Truini A., Prosperini L., Calistri V., et al. A dual concurrent mechanism explains trigeminal neuralgia in patients with multiple sclerosis. Neurology. 2016; 86(22): 2094–2099. DOI: 10.1212/WNL.0000000000002720. PMID: 27164695.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Broggi G., Ferroli P., Franzini A., et al. Microvascular decompression for trigeminal neuralgia: comments on a series of 250 cases, including 10 patients with multiple sclerosis. J Neurol Neurosurg Psychiatr. 2000; 68(1): 59–64. DOI: 10.1136/jnnp.68.1.59. PMID: 10601403.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Tyurnikov V.M., Peresedova A.V., Gushcha A.O., Koval K.V. Experience in the use of high-frequency selective percutaneous rhizotomy in trigeminal neuralgia associated with multiple sclerosis. Zh Vopr Neirokhir Im N N Burdenko. 2015; 79(5): 34–42. DOI: 10.17116/neiro201579534-42. PMID: 26528611.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Berk C., Constantoyannis C., Honey C.R. The treatment of trigeminal neuralgia in patients with multiple sclerosis using percutaneous radiofrequency rhizotomy. Can J Neurol Sci. 2003; 30(3): 220–223. DOI: 10.1017/s0317167100002626. PMID: 12945945.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Leandri M., Lunardi G., Inglese M., et al. Lamotrigine in trigeminal neuralgia secondary to multiple sclerosis. J Neurol. 2000; 247(7): 556–558. DOI: 10.1007/s004150070157. PMID: 10993501.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Solaro C., Boehmker M., Tanganelli P. Pregabalin for treating paroxysmal painful symptoms in multiple sclerosis: a pilot study. J Neurol. 2009; 256(10): 1773–1774. DOI: 10.1007/s00415-009-5203-6. PMID: 19579001.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Solaro C.M., Ferriero G. Refactory trigeminal neuralgia successfully treated by combination therapy (Pregabalin plus lamotrigine). Mult Scler Relat Disord. 2018; 25: 165–166. DOI: 10.1016/j.msard.2018.07.027. PMID: 30081317.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Pfau G., Brinkers M., Treuheit T., et al. Misoprostol as a therapeutic option for trigeminal neuralgia in patients with multiple sclerosis. Pain Med. 2012; 13(10): 1377–1378. DOI: 10.1111/j.1526-4637.2012.01472.x. PMID: 22925476.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Zakrzewska J.M., Palmer J., Morisset V., et al. Safety and efficacy of a Nav1. 7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial. Lancet Neurol. 2017; 16(4): 291–300. DOI: 10.1016/S1474-4422(17)30005-4. PMID: 28216232.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Texakalidis P., Xenos D., Karras C.L., Rosenow J.M. Percutaneous surgical approaches in multiple sclerosis-related trigeminal neuralgia: a systematic review and meta-analysis. World Neurosurg. 2020. S1878-8750(20)32381-0. DOI: 10.1016/j.wneu.2020.11.006. PMID: 33171325.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Krishnan S., Bigder M., Kaufmann A.M. Long-term follow-up of multimodality treatment for multiple sclerosis-related trigeminal neuralgia. Acta Neurochir (Wien). 2018; 160(1): 135–144. DOI: 10.1007/s00701-017-3383-x. PMID: 29167978.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Patwardhan R.V., Minagar A., Kelley R.E., Nanda A. Neurosurgical treatment of multiple sclerosis. Neurol Res. 2006; 28(3): 320–325. DOI: 10.1179/016164106X98224. PMID: 16687060.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Sandell T., Eide P.K. The effect of microvascular decompression in patients with multiple sclerosis and trigeminal neuralgia. Neurosurgery. 2010; 67(3): 749–754. DOI: 10.1227/01.NEU.0000375491.81803.5D. PMID: 20651626.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Mohammad-Mohammadi A., Recinos P.F., Lee J.H. et al. Surgical outcomes of trigeminal neuralgia in patients with multiple sclerosis. Neurosurgery. 2013; 73(6): 941–950. DOI: 10.1227/NEU.0000000000000128. PMID: 23921703.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Cruccu G., Biasiotta A., Di Rezze S., et al. Trigeminal neuralgia and pain related to multiple sclerosis. Pain. 2009; 143(3): 186–191. DOI: 10.1016/j.pain.2008.12.026. PMID: 19171430.</mixed-citation></ref></ref-list></back></article>
